Showing results (501-510 of 566) with videos related to

Sort By:
Pageof 57
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2009
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependenceEllen E Codd, John R Carson, Raymond W Colburn, et al.
American Journal of Epidemiology|November 27, 2025
Augmenting fact and date of death in electronic health records using internet media sources: a validation study from two large healthcare systemsMichele LeNoue-Newton, Mohammed Al-Garadi, Kerry Ngan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2006
The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216E E Codd, J R Carson, R W Colburn, et al.
Molecular Neurobiology|July 1, 2016
Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived NeuronsXiaozhuo Liu, Emilie Campanac, Hoi-Hung Cheung, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2013
Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonistsBin Zhu, Mingde Xia, Xiaoqing Xu, et al.
JNCI Cancer Spectrum|May 31, 2021
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With ImmunotherapyDaniel V Araujo, Ao Wang, Dax Torti, et al.
Cancer Research Communications|March 2, 2023
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal MelanomaDerek Wong, Ping Luo, Nadia Znassi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 10, 2005
Indirect recognition of MHC class I allopeptides accelerates lung allograft rejection in miniature swineTsuyoshi Shoji, John C Wain, Stuart L Houser, et al.
The Journal of Rheumatology|July 1, 2024
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial SpondyloarthritisSherry Rohekar, Jordi Pardo Pardo, Reza Mirza, et al.
Rheumatology (Oxford, England)|November 2, 2021
Impact of the COVID-19 pandemic on juvenile idiopathic arthritis presentation and research recruitment: results from the CAPRI registryMolly J Dushnicky, Catherine Campbell, Karen A Beattie, et al.
Pageof 57